Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

TVGN vs ILLR: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

TVGN Wins Head-to-Head Institutional Verdict (2–2 across 6 Pillars · 6–0 Matrix Metrics)

TVGN Overall Winner 6-Pillar Tally: TVGN 2 – 2 ILLR (2 Tie) Matrix Metrics: TVGN 6 – 0 ILLR

As of Nov 16, 2026, Tevogen Bio Holdings Inc. (TVGN) is the stronger overall head-to-head candidate over Triller Group Inc. (ILLR) in the Tradestie Institutional Equity Comparison Engine, winning 6–0 core matrix metrics and 2–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality). TVGN carries a Unified Composite Score of 60.3/100 (BUY) at $6.02 (N/M Forward P/E, 0.0% operating margin), whereas ILLR carries 48.6/100 (HOLD) at $0.18 (N/M Forward P/E, -432.7% operating margin).

  • Technical & Structure Timing Caution: TVGN trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 47.2); meanwhile ILLR is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 17.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About TVGN vs ILLR
TVGN NASDAQ Head-to-Head Winner
Tevogen Bio Holdings Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$6.02
+0.41% 1D
Market Cap $387.6M
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 1.61β · 60% Vol
Unified Composite Score
60.3 / 100 BUY
Tech 97.0 Fund 50.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 47
RSI-14: 47.2 · SMA20: $6.05 · SMA50: $6.70
ILLR NASDAQ
Triller Group Inc. Common Stock
Investment Advice
$0.18
-23.04% 1D
Market Cap $4.7M
TTM Revenue $22M
Forward P/E N/M
Beta / 30D Vol -10.16β · 177% Vol
Unified Composite Score
48.6 / 100 HOLD
Tech 45.0 Fund 49.0 Flow 50.0 Mom 55.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -44.3%), weak momentum, RSI 18
RSI-14: 17.8 · SMA20: $0.46 · SMA50: $0.80

6-Pillar Scorecard Institutional Category Breakdown (TVGN 2 – 2 ILLR)

Columns: Metric · TVGN · ILLR
1. Valuation Multiples ILLR
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue N/M 0.2x
2. Growth & Scale TVGN
Revenue Growth (YoY) +0.0% -5.2%
Earnings Growth (YoY) +0.0% +0.0%
TTM Revenue (USD) N/A $22M
Market Cap $387.6M $4.7M
3. Profitability & Quality TVGN
Gross Margin N/A N/A
Operating Margin 0.0% -432.7%
Net Profit Margin 0.0% 0.0%
Return on Equity (ROE) 0.0% 0.0%
4. Balance Sheet & Cash Flow ILLR
Cash Generation (TTM) N/A -$144M EBITDA
Cash Flow Margin N/A N/A
Net Cash / Leverage 0.0% ROE 0.0% ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Markdown
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Biotechnology Operator Software - Application Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: TVGN (6) vs ILLR (0)
Institutional Metric TVGN ILLR Criterion Row Edge
Market Capitalization
Scale
$387.6M $4.7M Larger Scale TVGN
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
+0.0% -5.2% Higher Growth TVGN
Operating Margin (TTM)
Profitability
0.0% -432.7% Higher Margin TVGN
Net Profit Margin
Profitability
0.0% 0.0% Higher Margin Tie
Return on Equity (ROE)
Capital Efficiency
0.0% 0.0% Higher ROE Tie
52-Week Range Position
Momentum
50% ($0–$12) 1% ($0–$5) Stronger Trend TVGN
Beta / 30D Volatility
Risk Regime
1.61β · 60% Vol -10.16β · 177% Vol Lower Realized Risk TVGN
Unified Institutional Score
Composite Signal
60.3 / 100 (BUY) 48.6 / 100 (HOLD) Higher Composite TVGN
Trailing 12M Revenue (USD)
Operating Scale
N/A $22M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · 0.2x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A (0.0% ROE) -$144M EBITDA (0.0% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon TVGN +71.45 pp
TVGN: -9.48% · ILLR: -80.93%
3M Horizon TVGN +110.75 pp
TVGN: +18.0% · ILLR: -92.75%
6M Horizon TVGN +1666.24 pp
TVGN: +1590.54% · ILLR: -75.7%
1Y Horizon TVGN +1360.34 pp
TVGN: +1292.7% · ILLR: -67.64%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on TVGN vs ILLR. Trailing 12-month operating profitability (TVGN 0.0% vs ILLR -432.7%) and valuation multiples (TVGN N/M vs ILLR N/M Forward P/E) are benchmarked directly in Pillar 4 below.

TVGN ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. Margin0.0%
ROE / Fwd P/E0.0% · N/M
ILLR ADR TTM Benchmark FX-Normalized USD
TTM Revenue$22M
Gross MarginN/A
Op. Margin-432.7%
ROE / Fwd P/E0.0% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
TVGN UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact TVGN Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
ILLR UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact ILLR Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
TVGN Moat Profile Cyclical / Execution-Driven Positioning
Biotechnology Operator
Competes within the Biotechnology value chain with $387.6M market capitalization and 0.0% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
ILLR Moat Profile Cyclical / Execution-Driven Positioning
Software - Application Operator
Competes within the Software - Application value chain with $4.7M market capitalization and -432.7% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ TVGN vs ILLR Key Questions & Quantitative Answers

As of Nov 16, 2026, Tevogen Bio Holdings Inc. (TVGN) is the stronger overall head-to-head candidate over Triller Group Inc. (ILLR) in the Tradestie Institutional Equity Comparison Engine, winning 6–0 core matrix metrics and 2–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality). TVGN carries a Unified Composite Score of 60.3/100 (BUY) at $6.02 (N/M Forward P/E, 0.0% operating margin), whereas ILLR carries 48.6/100 (HOLD) at $0.18 (N/M Forward P/E, -432.7% operating margin). Technical & Structure Timing Caution: TVGN trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 47.2); meanwhile ILLR is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 17.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

TVGN leads the Growth & Scale pillar: TVGN posts +0.0% YoY revenue growth and +0.0% YoY earnings growth on N/A TTM revenue (N/A gross margin, 0.0% operating margin), compared with ILLR at -5.2% YoY revenue growth and +0.0% YoY earnings growth on $22M TTM revenue (N/A gross margin, -432.7% operating margin). On trailing 12-month operating scale, TVGN generates N/A in USD-normalized revenue versus $22M for ILLR. In operating R&D and SG&A reinvestment, TVGN deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for ILLR.

ILLR screens cheaper on headline valuation multiples. TVGN trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas ILLR trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.2x EV/Revenue (unreported EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against TVGN (0.0% ROE) versus ILLR (0.0% ROE) capital efficiency.

In options market volatility and institutional positioning, TVGN carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.61β · 60% Vol realized risk). By comparison, ILLR carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-10.16β · 177% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.